Effect of candesartan treatment on left ventricular remodeling after aortic valve replacement for aortic stenosis

American Journal of Cardiology

Volumn 106, Issue 5, 2010, Pages 713-719

  Dahl, Jordi S ^a   Videbaek, Lars ^a   Poulsen, Mikael K ^a   Pellikka, Patricia A ^c   Veien, Karsten ^a   Andersen, Lars Ib ^a   Haghfelt, Torben ^a   Møller, Jacob E ^b  

^a ODENSE UNIVERSITY HOSPITAL   (Denmark)

^b Rigshospitalet   (Denmark)

^c MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CANDESARTAN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; BENZIMIDAZOLE DERIVATIVE; TETRAZOLE DERIVATIVE;

ADULT; AGED; AORTA STENOSIS; AORTA VALVE PROSTHESIS; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG DOSE TITRATION; DRUG WITHDRAWAL; FEMALE; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HEART VENTRICLE REMODELING; HUMAN; HYPERTENSION; HYPOTENSION; LINEAR REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; POSTOPERATIVE CARE; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; AORTIC VALVE STENOSIS; COHORT ANALYSIS; COMPLICATION; DRUG ADMINISTRATION; ECHOGRAPHY; HEART VALVE REPLACEMENT; HYPERTROPHY, LEFT VENTRICULAR; MIDDLE AGED; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; AORTIC VALVE STENOSIS; BENZIMIDAZOLES; COHORT STUDIES; DRUG ADMINISTRATION SCHEDULE; FEMALE; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; MALE; MIDDLE AGED; SEVERITY OF ILLNESS INDEX; TETRAZOLES; TREATMENT OUTCOME; VENTRICULAR REMODELING;

EID: 77955921453     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2010.04.028     Document Type: Article

References (29)

1. E.S. Monrad, O.M. Hess, T. Murakami, H. Nonogi, W.J. Corin, and H.P. Krayenbuehl Time course of regression of left ventricular hypertrophy after aortic valve replacement Circulation 77 1988 1345 1355
2. O. Lund, M. Erlandsen, I. Dorup, K. Emmertsen, C. Flo, and F.T. Jensen Predictable changes in left ventricular mass and function during ten years after valve replacement for aortic stenosis J Heart Valve Dis 13 2004 357 368
3. T. Walther, V. Falk, G. Langebartels, M. Kruger, U. Bernhardt, A. Diegeler, J. Gummert, R. Autschbach, and F.W. Mohr Prospectively randomized evaluation of stentless versus conventional biological aortic valves: impact on early regression of left ventricular hypertrophy Circulation 100 suppl 1999 II6 I10
4. M. Gaudino, F. Alessandrini, F. Glieca, N. Luciani, C. Cellini, C. Pragliola, M. Morelli, C. Canosa, G. Nasso, and G. Possati Survival after aortic valve replacement for aortic stenosis: does left ventricular mass regression have a clinical correlate? Eur Heart J 26 2005 51 57
5. A.D. Perez de, B. Lees, M. Flather, F. Nugara, T. Husebye, M. Jasinski, M. Cisowski, M. Khan, M. Henein, J. Gaer, L. Guvendik, A. Bochenek, S. Wos, M. Lie, N.G. Van, D. Pennell, and J. Pepper Randomized comparison of stentless versus stented valves for aortic stenosis: effects on left ventricular mass Circulation 112 2005 2696 2702
6. O. Lund, K. Emmertsen, I. Dorup, F.T. Jensen, and C. Flo Regression of left ventricular hypertrophy during 10 years after valve replacement for aortic stenosis is related to the preoperative risk profile Eur Heart J 24 2003 1437 1446
7. R.B. Devereux, K. Wachtell, E. Gerdts, K. Boman, M.S. Nieminen, V. Papademetriou, J. Rokkedal, K. Harris, P. Aurup, and B. Dahlof Prognostic significance of left ventricular mass change during treatment of hypertension JAMA 292 2004 2350 2356
8. R.B. Devereux, B. Dahlof, E. Gerdts, K. Boman, M.S. Nieminen, V. Papademetriou, J. Rokkedal, K.E. Harris, J.M. Edelman, and K. Wachtell Regression of hypertensive left ventricular hypertrophy by losartan compared with atenolol: the Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) trial Circulation 110 2004 1456 1462 (Pubitemid 39238023)
9. R.M. Lang, M. Bierig, R.B. Devereux, F.A. Flachskampf, E. Foster, P.A. Pellikka, M.H. Picard, M.J. Roman, J. Seward, J.S. Shanewise, S.D. Solomon, K.T. Spencer, M.S. Sutton, and W.J. Stewart Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a Branch of the European Society of Cardiology J Am Soc Echocardiogr 18 2005 1440 1463
10. R.B. Devereux, P.N. Casale, P. Kligfield, R.R. Eisenberg, D. Miller, E. Campo, and D.R. Alonso Performance of primary and derived M-mode echocardiographic measurements for detection of left ventricular hypertrophy in necropsied subjects and in patients with systemic hypertension, mitral regurgitation and dilated cardiomyopathy Am J Cardiol 57 1986 1388 1393
11. S.F. Nagueh, C.P. Appleton, T.C. Gillebert, P.N. Marino, J.K. Oh, O.A. Smiseth, A.D. Waggoner, F.A. Flachskampf, P.A. Pellikka, and A. Evangelista Recommendations for the evaluation of left ventricular diastolic function by echocardiography J Am Soc Echocardiogr 22 2009 107 133
12. V. Palmieri, B. Dahlof, V. DeQuattro, N. Sharpe, J.N. Bella, G. de Simone, M. Paranicas, D. Fishman, and R.B. Devereux Reliability of echocardiographic assessment of left ventricular structure and function: the PRESERVE study Prospective Randomized Study Evaluating Regression of Ventricular Enlargement J Am Coll Cardiol 34 1999 1625 1632
13. A.W. Haider, M.G. Larson, E.J. Benjamin, and D. Levy Increased left ventricular mass and hypertrophy are associated with increased risk for sudden death J Am Coll Cardiol 32 1998 1454 1459
14. D. Levy, R.J. Garrison, D.D. Savage, W.B. Kannel, and W.P. Castelli Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study N Engl J Med 322 1990 1561 1566
15. P. Verdecchia, G. Schillaci, C. Borgioni, A. Ciucci, R. Gattobigio, I. Zampi, G. Reboldi, and C. Porcellati Prognostic significance of serial changes in left ventricular mass in essential hypertension Circulation 97 1998 48 54 (Pubitemid 28036154)
16. J. Mathew, P. Sleight, E. Lonn, D. Johnstone, J. Pogue, Q. Yi, J. Bosch, B. Sussex, J. Probstfield, and S. Yusuf Reduction of cardiovascular risk by regression of electrocardiographic markers of left ventricular hypertrophy by the angiotensin-converting enzyme inhibitor ramipril Circulation 104 2001 1615 1621
17. E.O. Weinberg, F.J. Schoen, D. George, Y. Kagaya, P.S. Douglas, S.E. Litwin, H. Schunkert, C.R. Benedict, and B.H. Lorell Angiotensin-converting enzyme inhibition prolongs survival and modifies the transition to heart failure in rats with pressure overload hypertrophy due to ascending aortic stenosis Circulation 90 1994 1410 1422
18. M. Kojima, I. Shiojima, T. Yamazaki, I. Komuro, Z. Zou, Y. Wang, T. Mizuno, K. Ueki, K. Tobe, and T. Kadowaki Angiotensin II receptor antagonist TCV-116 induces regression of hypertensive left ventricular hypertrophy in vivo and inhibits the intracellular signaling pathway of stretch-mediated cardiomyocyte hypertrophy in vitro Circulation 89 1994 2204 2211
19. K. Malmqvist, T. Kahan, M. Edner, C. Held, A. Hagg, L. Lind, R. Muller-Brunotte, F. Nystrom, K.P. Ohman, M.D. Osbakken, and J. Ostergern Regression of left ventricular hypertrophy in human hypertension with irbesartan J Hypertens 19 2001 1167 1176
20. P.A. Thurmann, P. Kenedi, A. Schmidt, S. Harder, and N. Rietbrock Influence of the angiotensin II antagonist valsartan on left ventricular hypertrophy in patients with essential hypertension Circulation 98 1998 2037 2042
21. B. Iung, G. Baron, E.G. Butchart, F. Delahaye, C. Gohlke-Barwolf, O.W. Levang, P. Tornos, J.L. Vanoverschelde, F. Vermeer, E. Boersma, P. Ravaud, and A. Vahanian A prospective survey of patients with valvular heart disease in Europe: the Euro Heart Survey on Valvular Heart Disease Eur Heart J 24 2003 1231 1243
22. B. Williams, P.S. Lacy, S.M. Thom, K. Cruickshank, A. Stanton, D. Collier, A.D. Hughes, H. Thurston, and M. O'Rourke Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: principal results of the Conduit Artery Function Evaluation (CAFE) study Circulation 113 2006 1213 1225
23. S.D. Solomon, R. Janardhanan, A. Verma, M. Bourgoun, W.L. Daley, D. Purkayastha, Y. Lacourciere, S.E. Hippler, H. Fields, T.Z. Naqvi, S.L. Mulvagh, J.M. Arnold, J.D. Thomas, M.R. Zile, and G.P. Aurigemma Effect of angiotensin receptor blockade and antihypertensive drugs on diastolic function in patients with hypertension and diastolic dysfunction: a randomised trial Lancet 369 2007 2079 2087
24. K. Wachtell, J.N. Bella, J. Rokkedal, V. Palmieri, V. Papademetriou, B. Dahlof, T. Aalto, E. Gerdts, and R.B. Devereux Change in diastolic left ventricular filling after one year of antihypertensive treatment: the Losartan Intervention For Endpoint Reduction in Hypertension (LIFE) Study Circulation 105 2002 1071 1076 (Pubitemid 34212616)
25. E. Gerdts, K. Wachtell, P. Omvik, J.E. Otterstad, L. Oikarinen, K. Boman, B. Dahlof, and R.B. Devereux Left atrial size and risk of major cardiovascular events during antihypertensive treatment: losartan intervention for endpoint reduction in hypertension trial Hypertension 49 2007 311 316
26. S.H. Poulsen, P. Sogaard, J.E. Nielsen-Kudsk, and H. Egeblad Recovery of left ventricular systolic longitudinal strain after valve replacement in aortic stenosis and relation to natriuretic peptides J Am Soc Echocardiogr 20 2007 877 884
27. S.F. Nagueh, K.J. Middleton, H.A. Kopelen, W.A. Zoghbi, and M.A. Quinones Doppler tissue imaging: a noninvasive technique for evaluation of left ventricular relaxation and estimation of filling pressures J Am Coll Cardiol 30 1997 1527 1533
28. W. Mullens, A.G. Borowski, R.J. Curtin, J.D. Thomas, and W.H. Tang Tissue Doppler imaging in the estimation of intracardiac filling pressure in decompensated patients with advanced systolic heart failure Circulation 119 2009 62 70
29. M. Dalsgaard, J. Kjaergaard, R. Pecini, K.K. Iversen, L. Kober, J.E. Moller, P. Grande, P. Clemmensen, and C. Hassager Left ventricular filling pressure estimation at rest and during exercise in patients with severe aortic valve stenosis: comparison of echocardiographic and invasive measurements J Am Soc Echocardiogr 22 2009 343 349